InvestorsHub Logo
Followers 37
Posts 1455
Boards Moderated 0
Alias Born 03/06/2014

Re: someday7 post# 7324

Friday, 08/12/2016 12:33:12 PM

Friday, August 12, 2016 12:33:12 PM

Post# of 9772
Barely able to use and not necessary at this point. Results of the phase study will tell all as stated before. As for the Q10, some dilution as expected. The rest of the numbers were solid. Plenty of cash for the next 12 months. Grants and contracts will continue to flow in at the tune of 37.1 million. Whats not to like here Someday? All is right on track for success down the road.
Was thinking back on your comment about the FDA caring little about approving trials from Phase II to Phase III. I have data but look it up yourself. If you think the FDA just pushes drugs through to the final phase you're going to be very surprised at the percentage drop off from II to III. Not something to take lightly especially in the efficacy category when dealing with peoples well being!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNGX News